The cyclic AMP pathway is a major regulator of thyrocyte function and proliferation and, predictably, its inappropriate activation is associated with a sub-set of human thyroid tumours. Activating mutations are, however, more common in the thyrotropin receptor (TSHR) than in its downstream transducer, Gas. To investigate whether this re¯ects an inherent dierence in their oncogenic potency, we compared the eects of retrovirally-transduced mutant (A623I) TSHR or (Q227L) Gas (GSP), using the rat thyroid cell line FRTL5 and primary human thyrocytes. In FRTL5, expression of GSP or mutant (m) TSHR induced a 2 ± 3-fold increase in basal levels of cAMP. This was associated with TSH-independent proliferation (assessed by both cell number and DNA synthesis) and function (as shown by increased expression of thyroglobulin (Tg) and the sodium/iodide symporter). In primary cultures, expression of mTSHR, but not GSP, consistently induced formation of colonies with epithelial morphology and thyroglobulin expression, capable of 10 ± 15 population doublings (PD) compared to less than three in controls. Thus, while mTSHR and GSP exert similar eects in FRTL5, use of primary cultures reveals a major dierence in their ability to induce sustained proliferation in normal human thyrocytes, and provides the ®rst direct evidence that mTSHR is sucient to initiate thyroid tumorigenesis.
Introduction
In physiological conditions, growth and function of thyroid follicular epithelial cells are regulated principally by binding of thyrotropin (TSH) to its receptor (TSHR) which then activates adenylate cyclase and the cAMP cascade via the hetero-trimeric transducer protein Gs (Vassart and Dumont, 1992) . In a variety of inherited and acquired pathological states, thyroid hyperfunction and proliferation are associated with activating mutations in elements of this signal pathway, notably TSHR itself Russo et al., 1996; Parma et al., 1997; Fuhrer et al., 1997) and the a sub-unit of the Gs protein (O'Sullivan et al., 1991; Russo et al., 1995a,b; Parma et al., 1997; Fuhrer et al., 1997) .
To date, two mutations in Gas (GSP) have been identi®ed, Q227L and R201H, which activate the protein by`locking' it in its GTP-bound signalling conformation. In contrast, ligand-independent activation of TSHR can occur through point mutation at more than 20 dierent sites, the majority clustered in its trans-membrane and intra-cellular domains (reviewed in Paschke et al., 1994) . In thyroid neoplasia, point mutations are found, as would be predicted, mainly in the sub-set of benign tumours which display both increased growth and hyperfunction, i.e. autonomously functioning`toxic adenomas' or`hot nodules'. More rarely they can also occur in cancers (Said et al., 1994; Russo et al., 1995a; Paschke and Ludgate 1997) which have elevated cAMP levels but, due presumably to loss of dierentiation, do not exhibit increased thyroid hormone secretion.
Interestingly, however, in all thyroid tumour types the prevalence of mutation of GSP appears to be much lower than that of TSHR despite the fact that both might be expected to have the same ability to activate the cAMP pathway. In four series totalling 114 cases of hot nodule' (O'Sullivan et al., 1991; Russo et al., 1995b Russo et al., , 1996 Parma et al., 1997 ) the frequency of GSP mutation varied from 0% (Fuhrer et al., 1997) to 38% (O'Sullivan et al., 1991) with a weighted mean of 14%. In contrast, TSHR mutation varied from 20% (Russo et al., 1996) to 82% (Parma et al., 1997) with a mean of 47%. Since this is probably an underestimate, given the greater potential for missing mutations in TSHR, the latter must be at least 3 ± 4-fold more common than mutation of GSP.
This dierence in prevalence may of course itself merely re¯ect the greater range of functionally signi®cant targets for mutation in TSHR (at least 20 codons) compared to GSP (only two). More interestingly, though, it could alternatively be due to an inherently greater biological potency of mTSHR as an oncogene, which may result from its ability to activate signal transduction pathways additional to cAMP; it is already known for example that at least some mutants stimulate phospholipase C and the inositol phosphate cascade . This issue has not been adequately addressed.
Most signalling studies in this ®eld have been performed, for ease of experimental manipulation, by expression of mutant genes in non-thyroid rodent cell lines (Parma et al., 1993; Paschke et al., 1994) which are inappropriate for assessing their relative proliferogenic eects on thyroid cells. Even where cells of thyroid origin have been used, this has nearly always been the rat thyrocyte cell line FRTL5. In the case of GSP, expression of the Q227L mutant conferred complete TSH independence for DNA synthesis (Muca and Vallar, 1994) but, interestingly, required the addition of forskolin to achieve the same increase in cell number as induced by TSH in control cells. Similar results were obtained using the PDE inhibitor, rolipram (Nemoz et al., 1995) . TSH-independent proliferation has also been seen with mTSHR, the extent varying in one study with the nature of the mutant (Porcellini et al., 1997) , although it was not clear whether even the most potent construct (T632I) reached the level of TSH stimulated controls. In another study, comparing the M453T mutant with GSP, only the mutant receptor was able to induce clones with anchorage-independence and tumorigenicity in nude mice (Fournes et al., 1998) , providing a ®rst hint that mTSHR may be a more potent oncogene.
Published FRTL5 studies all suer from limitations however. Some were performed on pools of clones (Porcellini et al., 1997) which, given the heterogeneity of the response expected in gene transfer experiments, can lead to information being lost due either to overgrowth of more vigorously growing clones or by a dilution eect from clones with low expression of the transgene. Others involved selection of individual clones based on their ability to overgrow the background culture in the absence of TSH (Fournes et al., 1998) , which introduces a strong bias for the most proliferative phenotype and risks masking dierences in potency between GSP and TSHR. Furthermore, most previous studies have examined only eects on proliferation rather than dierentiated thyrocyte functions. Finally, in FRTL5, TSH has little eect on phospholipase C unless highly unphysiological concentrations of hormone are used (Vassart and Dumont, 1992) , indicating that these cells may not be a good model system to investigate phenotypic responses dependent on this pathway.
Primary human cells are obviously the ideal experimental model to test the ability of a putative oncogene to initiate tumour development and we have successfully employed retrovirus vectors to demonstrate this for two other thyroid oncogenes, RAS and RET (Bond et al., 1994) . However, in a recent study (Ivan et al., 1997 ) using a retroviral vector expressing Q227L GSP, we found that despite performing infections in a variety of conditions in which the positive control ± mutant RAS ± generated large numbers of colonies, expression of GSP in human thyrocytes in primary monolayer cultures induced only morphological responses (cytoskeletal changes and cellular hypertrophy), with very little proliferation. These in vitro ®ndings are in general in agreement with in vivo studies in mice transgenic for the R201H GSP mutant (Michiels et al., 1994) under the control of the bovine thyroglobulin promoter. These mice developed only late-onset sporadic thyroid nodules, rather than the expected generalized hyperplasia, suggesting either that only a tiny sub-population of follicular cells are sensitive to this growth stimulus, or more likely that there is a need for a second oncogenic event.
Taken together these data suggest that GSP mutation alone may be insucient to account for the formation of a thyroid tumour and that the observed predominance of TSHR mutations may indeed re¯ect its greater biological potency. The purposes of this study were therefore to compare in more detail the eects of GSP and mutant TSHR on growth and function in FRTL5 cells, using a phenotypically neutral method of clonal selection, and furthermore, to compare their biological eects on human primary thyrocytes.
Results
Eect of GSP, wild-type and mutant TSHR expression on FRTL5 cells Selection of clones following retroviral infection Monolayers of FRTL-5 (SB5 sub-clone; Burns et al., 1992) were infected with retroviral vectors encoding: (i) mutant GSP (rat Q227L); (ii) mutant TSHR (human A623I); (iii) wild-type (wt) TSHR or (iv) neo-only (control) genes. From each infection, several hundred G418-resistant clones were obtained, from which six were picked at random for preliminary analysis (data not shown). The GSP clones were clearly very heterogeneous in behaviour. In the absence of TSH, two had growth rates comparable to that of neo controls in the presence of TSH, while the remaining four showed varying degrees of TSH dependence, two of which also displayed increased cellular size (area) and altered cytoplasmic morphology. Three clones were selected to represent this range of phenotypes: gsp6 (TSH-independent); gsp1 (partially TSH-dependent); and gsp8 (partially TSH-dependent plus morphological change). The six mTSHR clones were similarly heterogeneous, and again, three representative clones were selected for detailed study: MT1 (TSHindependent); MT2 (partially TSH-dependent) and MT3 (partially TSH-dependent with morphological change). The six wtTSHR clones were much more homogeneous. None proliferated in the absence of TSH and there were no morphological changes. Three were therefore selected at random: WT1, WT4 and WT6 (in some experiments only the last two were included). The neo-only clones were also homogeneous and so to limit the total number of clones which needed to be analysed in later experiments, these were pooled to form a single control population (neo).
Eects on proliferation
Cell number (Figure 1a and b; Table 1) Control (neo) cells in the absence of TSH showed a consistent initial reduction of *40% in cell number at day 2 (due presumably to failure of some cells to attach). Thereafter there was a slow recovery, returning by day 7 to the number seeded. In the presence of TSH (5 mU/ml) there was no initial cell loss, and nearexponential growth leading to a 6 ± 7-fold increase by day 7.
In the absence of TSH, the wtTSHR clones behaved almost identically to the neo population. In contrast, both the GSP and mTSHR clones all showed some degree of TSH-independence. Although all but two (gsp6 and 8) suered the initial cell loss, this was followed by a period of exponential growth with doubling times similar to that of TSH-stimulated neo cells (with the exception of gsp8). Cell numbers attained by day 7 were therefore intermediate between those seen in neo controls in the absence and presence of TSH. The highest values, displayed by clones gsp6 and MT1, were not signi®cantly lower than that of neo plus TSH.
In the presence of TSH (Figure 1b ), the initial loss in cell number was less marked but interestingly nearly all GSP, wt and mTSHR clones still showed lower numbers than neo controls at day 2. Thereafter, though, all clones grew at rates similar to or greater than neo, and reached larger ®nal cell numbers at day 7, the highest values being seen in the three mTSHR clones.
DNA synthesis (Table 1) In the absence of TSH, *30% of the control (neo) cells incorporated BrdU during a 24 h labelling period corresponding to days 3 ± 4 of the growth curves. This was surprising given that no increase in cell number occurred during this time and presumably re¯ects either ongoing cell death or DNA synthesis without cell division (endoreduplication). In the presence of TSH, the BrdU LI increased to *70%.
In the absence of TSH, clones expressing wt TSHR had an LI very close to that of the neo control. In contrast, all the GSP and mTSHR clones showed much higher values, in two cases (gsp6 and MT1), reaching levels not signi®cantly lower than that seen in neo in the presence of TSH.
Eect on tissue-speci®c dierentiation
Morphology In the absence of TSH, control neo cells exhibited a¯attened morphology which was restored to the normal, more cuboidal, shape within 24 ± 48 h of addition of TSH. In the absence of TSH, the wtTSHR clones closely resembled the neo controls, but GSP clones were less¯attened and the mTSHR clones resembled TSH-stimulated controls.
During the period of initial selection in G418, it was noticed that several groups of cells became enlarged and¯attened and displayed ®brillar changes in the cytoplasm reminiscent of`stress ®bres'. As selection proceeded, these changes disappeared in most clones, but remained a prominent feature in gsp8 and MT3 (Figure 2 ).
Basal cAMP The basal level of cAMP production in control neo cells in the absence of TSH was *30 fmoles/mg protein. Only one of the wtTSHR clones (WT1) had a signi®cantly higher level (160% of control; P50.01) ( Table 1) . In contrast, all of the GSP and mTSHR clones had basal levels ranging from 220 ± 330% of the neo control and similar or greater than those seen in neo cells in the presence of TSH.
Thyroglobulin expression In the absence of TSH, weak cytoplasmic immuno¯uorescence was observed with anti-Tg antibody in *40% of control neo cells, which increased to *50% in the presence of TSH, accompanied by a marked increase in intensity ( Figure  3 ). In contrast, in all TSHR or GSP expressing clones, even in the absence of TSH, the percentage of Tgpositive cells was similar to or higher than that seen in controls in the presence of TSH (Table 1) . Surprisingly, this also included the two wtTSHR clones, whose cAMP levels were not signi®cantly greater than the control values. The highest percentage of positive cells however was observed in the GSP and mTSHR clones, which also showed more intense¯uorescence than the wtTSHR cells (Figure 3) .
Expression of the Na + /I 7 symporter gene ( Figure  4 ) In the absence of TSH, transcripts were often below the limit of detection by RT ± PCR in control neo and wtTSHR clones. In contrast, detectable levels were present in all GSP and mTSHR clones. The highest levels were seen in MT2 and gsp6, the latter approaching that of TSH-stimulated neo controls (Table 1) . Results in the presence of the PDE inhibitor, IBMX, were largely as expected with an increase in the NIS transcript in the majority of cases ( Figure 4b ; Table 1 ). The exceptions were the two conditions showing highest levels in the absence of IBMX, i.e. gsp6 and neo plus TSH, in which a paradoxical reduction of NIS transcript levels was observed.
Eects of GSP, wt and mutant TSHR expression on primary human thyrocytes Primary thyrocytes in monolayer culture were infected with retroviral vectors either in 10% FCS or using a reduced-serum medium (1% FCS, supplemented with insulin and TSH) in an attempt to avoid the potential de-dierentiating eect of serum on thyroid cells. In both cases, a well-characterized retroviral vector encoding mutant H-RAS (Bond et al., 1994) was used as a positive control.
Colony formation in 10% FCS ( Figure 5 ) In 10% FCS, the H-RAS vector generated approximately 20 well-dierentiated epithelial colonies per dish of 5610 5 cells infected using thyrocytes from three out of four fresh and three out of eight stored samples (from 12 independent subjects). Most colonies were able to proliferate for at least 20 PD. The neo-only vector as expected failed to generate any colonies, consistent with the very limited proliferative capacity of normal human thyrocytes (Wynford-Thomas, 1993) . GSP also failed to induce any colony formation in 12 out of the 13 thyrocyte preparations infected and in the remaining case very few colonies were obtained.
In contrast, the mTSHR vector generated 10 ± 15 colonies of epithelial morphology per dish from four out of ®ve fresh and two out of eight stored thyrocyte samples. Typically, colonies grew for several weeks and reached a maximum size of 1000 ± 30 000 cells, equivalent to 10 ± 15 PD (assuming no cell death). Cessation of growth was associated with alterations in cellular morphology, characterized by spreading, attening and appearance of cytoplasmic stress ®bres with occasional pseudopodia (Figure 5 ). Similar results were obtained when thyrocytes derived from the same thyroids were infected with the wtTSHR vector, although with a lower yield (2 ± 5 colonies per dish). (1). (6100) It must be emphasized that these dierences in yield of colonies are not explicable by dierences in the titre of the corresponding vectors, at least as far as can be assessed using epithelial cell lines (FRTL5 and A431) as targets.
Colony formation in 1% FCS In 1% FCS colonies were obtained from two out of ®ve freshly disaggregated thyrocytes with a similar yield to that seen with 10% FCS, i.e. approximately 20 H-RAS, 10 mTSHR and two wtTSHR colonies per dish of 5610 5 infected. Proliferative capacity however was greatly reduced, being limited to no more than ®ve PD, even in the RAS colonies. In the case of TSHR this was accompanied by an early onset of morphological alterations including cellular¯attening and cytoskeletal changes. (Similar results were obtained irrespective of the inclusion of TSH at 0.03 or 5 mU/ml up to 1 day following retroviral infection.) Infection of stored follicles in 1% FCS was unsuccessful in all but one case due to poor cell attachment.
Expression of thyroglobulin To con®rm the cellular identity of the colonies obtained from primary culture, expression of Tg was analysed by immuno¯uorescence. In all colonies obtained with wt or mTSHR cytoplasmic positivity was observed in the majority of cells ( Figure 6 ). As observed with FRTL5, the intensity of immunostaining was greater with mTSHR than with wtTSHR as was the percentage of positive cells (74+4.5% and 51+4% respectively). 
Discussion

Activated GSP and TSHR both confer TSH-independent growth and function on FRTL5 cells
As expected, in FRTL5 (SB5) cells, expression of either activated Gas or TSHR was able to stimulate cAMP production and thyroglobulin expression, to levels similar to that induced by TSH. For Tg, a signi®cant increase was also induced by over-expression of wtTSHR, re¯ecting its limited constitutive activity Parma et al., 1993; Duprez et al., 1994) but interestingly this was not associated with any increase in cAMP. We also investigated expression of another recently cloned thyroid-speci®c gene ± the Na + /I 7 symporter (Dai et al., 1996) ± although the non-availability of antibodies restricted this to assessment of transcript abundance. Increased expression was seen in some GSP and mTSHR clones but to a more limited extent than for Tg, remaining well below the TSH-stimulated value in all but one clone. Since the corresponding cAMP levels were higher than those of TSH-stimulated controls this indicates the need for additional signal pathways. Furthermore, the inability of mTSHR to mimic extracellular TSH stimulation (the only example of this in our study) points to the involvement of pathway(s) whose stimulation by ligand binding must be quantitatively or qualitatively dierent from that following mutational activation. Nevertheless, NIS transcript levels approaching that induced by TSH could be achieved by inclusion of IBMX, implying that cAMP can be sucient at supra-physiological levels. Interestingly though, the paradoxical fall in NIS on addition of IBMX in conditions where it was already highly expressed (gsp6 and neo plus TSH) indicates that the optimal level of cAMP may be quite critical. Excessive levels are perhaps inhibitory through activation of ICER, an alternatively spliced form of the CREM transcription factor, which has already been demonstrated in the FRTL5 cell line (Lalli and Sassonecorsi, 1995).
GSP and mTSHR (but not wtTSHR) also conferred TSH-independent proliferation, as assessed both in terms of DNA synthesis and increase in cell number. Large variations were observed within each group, only one GSP and one mTSHR clone approaching complete TSH-independence. It is unlikely that this relates to dierences in expression of the mutant genes since (in contrast to one previous study (Porcellini et al., 1997) ) there was no consistent relationship to cyclic AMP levels. Expression was not measured directly here because basal cAMP was considered a more meaningful biological endpoint, and the only way to Table 1 eectively compare between GSP and mTSHR eects. The important ®nding for this study is that despite the inter-clonal variation, there was no signi®cant difference in the mean cAMP level or TSH-independent proliferative response between the GSP and TSHR clones, the respective basal cAMP levels (% of neo control) being 281+29% and 253+24%, with corresponding BrdU LI values of 57+5.6% and 54+6.5% (data derived from Table 1 ). Similar TSH-independent stimulation of cAMP and proliferation have been reported separately both for GSP (Muca and Vallar, 1994 ) and a range of TSHR mutants (Porcellini et al., 1997) but few functional parameters were examined. The only previous study to attempt a direct comparison between GSP and TSHR clones obtained from the same parent population (Fournes et al., 1998) concluded that GSP exerted a weaker eect than mTSHR (M453T) in terms of cAMP stimulation and doubling time in monolayer. However the former result was obtained in the presence of IBMX, and the latter may have been in¯uenced by the method of clonal selection (TSH-independent proliferation rather than`neutral' selection in G418).
On the basis of behaviour of FRTL5 cells in monolayer culture, the concensus from both the present and previous work is therefore that there is little or no evidence for dierence in the biological potencies of activated GSP and TSHR on which to explain their dierent mutational frequencies in thyroid tumours.
GSP and mTSHR exert very dierent eects on normal human thyrocytes
In contrast to the above, our data on primary cells reveals a massive dierence in the ability of mTSHR and GSP to induce sustained proliferation in normal thyrocytes. Unlike the FRTL5 line, these cells are normally capable of only a few cell divisions in culture, even in the presence of TSH Wynford-Thomas, 1993) . Whereas expression of GSP nearly always failed to stimulate proliferation, expression of mTSHR consistently generated colonies of Tgpositive epithelial cells which were able to proliferate for up to 15 PD Interestingly, although fewer in number, similar colonies could also be obtained by over-expression of the wtTSHR. Presumably, as was seen with Tg expression in FRTL5, this re¯ects its weak but signi®cant constitutive activity although, if so, it implies that the normal cells are more responsive than FRTL5, since no TSHindependent growth was observed with wtTSHR in the latter. Unfortunately, in the primary culture model, it was not possible to further investigate this by measurement of receptor expression or cAMP levels.
Constitutive TSHR activity provides a signal not mimicked by GSP or physiological TSH stimulation
The two major questions arising from the results with primary thyrocytes are: ®rstly, why GSP does not produce an eect equivalent to that of mTSHR and secondly, why is the latter so much more potent as a growth stimulus than stimulation by extracellular TSH.
One potentially artefactual explanation for the ineectiveness of GSP is that forced expression of a mutant Gas sub-unit does not mimic exactly the naturally occurring mutation in the endogenous gene because it does not lead to a corresponding release of free b/g sub-units. The latter can act in their own right as signal transducers, interacting for example with PI-3-kinase and tyrosine kinases (Van Biesen et al., 1996) , and could theoretically be required for the mitogenic response in primary cells. However, this would not explain the lack of sustained proliferation following administration of agents, notably cholera toxin (Wynford-Thomas, 1993) which activate endogenous Gs and closely mimic the eect of Gas mutation.
It seems most likely therefore that the essential signals missing in the case of GSP are derived from a pathway which diverges upstream of Gs, i.e. at the receptor itself. It is known that TSHR activates pathways additional to cAMP, notably the phospho-inositide pathway (via Gq and phospholipase-Cb) (Vassart and Dumont, 1992) and at least in one cell line model (Kupperman et al., 1993) there is evidence that cross-talk with RAS is involved in the mitogenic response. What is puzzling though is how expression of mTSHR can lead to sustained proliferation, whereas stimulation of normal thyrocytes by extra-cellular TSH does not lead to more than two or three PD either in vitro (Wynford- Thomas, 1993) or in the intact animal (Wynford-Thomas et al., Figure 6 Thyroglobulin expression in colonies of human thyrocytes derived by infection with vectors expressing: (1) wtTSHR; and (2) mTSHR. Rhodamine immuno¯uorescence (6150) 1982). One plausible explanation is that constitutive, ligand-independent, receptor signalling may not invoke receptor downregulation which is a well recognized response to ligand-mediated activation (Rapoport et al., 1982; Lalli and Sassonecorsi, 1995) . (Use of a heterologous promoter to drive TSHR in this and previous studies would, of course, circumvent the transcriptional component of down-regulation (Lalli and Sassonecorsi, 1995) but would not prevent receptor-G protein uncoupling (Rapoport et al., 1982) ).
Although in FRTL5, down-regulation is also known to occur (Lalli and Sassonecorsi, 1995) , its negative in¯uence must be of insucient magnitude to prevent a sustained proliferative response to TSH. Intriguingly though, dierential sensitivity of ligand-dependent and -independent stimulation to downregulatory control could provide an explanation for the observation (Fournes et al., 1998 ) that anchorage-independent opposed to monolayer growth of FRTL5 was strikingly stimulated by mTSHR, but not by TSHstimulation of the wt receptor (nor by GSP).
TSHR activation as an initiator of thyroid tumorigenesis
Irrespective of the above issues, our data show for the ®rst time that mTSHR is capable of driving clonal expansion of normal human thyrocytes, providing direct experimental support for its role as an initiating event in thyroid tumorigenesis, analogous to that already demonstrated by us for two other oncogenes ± RAS and RET (Bond et al., 1994) . As with the latter, proliferation eventually ceased, although after fewer PD, following which cells enter a state of growth arrest with morphological changes reminiscent of replicative senescence (Wynford-Thomas, 1997a) . The mechanism of this intrinsic limitation of clonal expansion is currently unknown although preliminary data suggest that, at least in the case of RAS, increased expression of the cyclin/CDK inhibitor p16
INK4a plays a role (Bond JA -unpublished) . Comparison of mTSHR colonies in 1% versus 10% FCS shows that the timing of this lifespan checkpoint can be modulated by the growth factor environment. Although the colony sizes observed in vitro would probably not be sucient to account for a clinically-evident tumour, this raises the important possibility that the environment in the intact organ may permit signi®cantly more PD to be achieved.
Clearly though, further tumour development beyond the initial self-limiting clone must be dependent on mutation of additional growth-regulatory genes, such as p16 ink4a (Wynford-Thomas, 1997a,b) . If, as suggested by our data, TSHR mutation usually generates smaller clones in vivo than does RAS, the chance of such a second event will be correspondingly smaller. This may be one explanation for the relative rarity of tumours initiated by TSHR mutation compared to RAS (when all tumour types are considered together), despite the much larger number of target sites for activating mutations in the TSHR gene.
Materials and methods
Production of retroviral vectors
The rat Q227L GSP and H-RAS amphotropic retroviral vectors driven by a MoMuLV LTR have been described previously (Bond et al., 1994; Ivan et al., 1997) . To construct TSHR vectors, cDNAs for the entire coding sequences of the wild-type (wt) and A623I mutant receptor (kindly provided by Dr G Vassart, IRIBHN, Brussels) were subcloned into plasmid pLNSX, which utilizes the SV40 early promoter for the gene of interest. (Attempts to clone mTSHR cDNA into LTR-driven vectors were, for unknown reasons, unsuccessful. However, previous comparison of the two promoters driving SV40T expression in primary thyrocytes did not reveal any detectable dierences in strength ± Bond JA, unpublished.) The resulting constructs, and the pLNSX control were transfected into the OE ecotropic packaging line and retroviral supernatants from pooled G418 resistant clones subsequently used to infect the amphotropic packaging line, Ccrip (Danos and Mulligan 1988) . Supernatants from a panel of G418 resistant Ccrip producer clones were evaluated using the human epithelial cell line A431 as a recipient. Viral titre was assessed in terms of the yield of G418 resistant colonies and, in the case of the TSHR vectors, stable expression was determined by measurement of speci®c [
125 I]TSH binding (Costagliola et al., 1994) . The optimum producer clones, all with titres 410 6 c.f.u./ml, were designated MLWT1 and MLAI1 for the wt and A623I mutant TSHR respectively, and MLSX1 for the LNSX neo-only control.
Cells and culture conditions
The SB5 subclone (Burns et al., 1992) of FRTL5, selected for its TSH dependency as previously described, which are referred to as`FRTL5' throughout. Cells were routinely cultured in a 2 : 1 : 1 mixture of DMEM, Ham's F12 and MCDB 104 supplemented with 5% calf serum (Life Technologies, Paisley, UK), 5 mU/ml bovine TSH (Sigma; UK), 10 mg/ml insulin, 10 78 M hydrocortisone, 45 mg/ml ascorbic acid and 5 mg/ml transferrin (`5H medium'). For experiments in basal conditions, cells were ®rst maintained in the same medium but lacking TSH (`4H medium') for at least 4 days.
Human primary thyrocytes were obtained by protease digestion of histologically-normal background tissue obtained from thyroidectomies performed for solitary nodules as previously described (Williams et al., 1988) . Monolayer cultures were maintained in a 2 : 1 : 1 mixture of DMEM, Ham's F12 and MCDB104 with 1% or 10% FCS (Life Technologies, Paisley, UK). In 1% FCS cultures, 10 mg/ml insulin and 5 mU/ml or 0.3 mU/ml bovine TSH were also included. Primary cultures from 13 dierent thyroids were used. Five were freshly disaggregated; in the remainder follicles had been stored frozen in DMSO prior to use.
Retroviral infection
Forty-eight hours after seeding in 5H medium, FRTL5 cells were pretreated for 1 h with 8 mg/ml polybrene and then exposed to retroviral supernatants for 2 h before refeeding with fresh medium. Cultures were passaged the following day, and after a further 24 h G418 selection commenced. Six G418-resistant clones from each GSP, wtTSHR and mTSHR infection were isolated, at random, using cloning rings. Pooled G418 resistant clones derived from the MLSX1 infected cells were used as a control neo-only population.
Primary human thyrocytes were similarly infected with retroviral supernatants 48 h after plating, and G418 selection started after a further 48 h. For experiments performed in 1% FCS, cultures were maintained in the presence of insulin throughout, but TSH (0.3 or 5 mU/ml) was included only up to the day following retroviral infection.
Proliferation assays (FRTL5 only)
Growth curves 5610 4 cells were seeded as multiple replicates in 24 well plates in 4H or 5H medium. Triplicate wells were trypsinized and counted at 2, 4 and 7 days and also at 11 days for cultures in 4H. Results are expressed as the mean of triplicates+standard error (s.e.).
DNA synthesis 5610 4 cells were seeded in 35 mm dishes, in 4H or 5H medium. Seventy-two hours later 10 mM BrdU was added for a further 24 h, following which monolayers were ®xed in 3.7% formaldehyde (15 min), permeabilized (0.2% Triton-X100) and immunostained using a mouse monoclonal anti-BrdU primary antibody (Boehringer-Mannheim), in the presence of 10 U/ml DNAse followed by¯uorescein-conjugated goat anti-mouse IgG (Southern Biotechnology). The percentage of labelled nuclei (LI) was determined from a count of 4300 per dish and results expressed as means of quadruplicate dishes+s.e.
cAMP assay
Five610
4 cells were seeded in 24 well plates in 4H medium. 72 ± 96 h later, the medium was replaced with Ham's F12 containing 1% BSA with varying concentrations of bovine TSH. After 4 h incubation cells were extracted in HCl, and extracts evaporated to dryness before resuspension in buer for cAMP determination using a commercial radioimmunoassay (Amersham, UK). Dierences in growth rate of the clones were corrected by measuring total cellular protein using a Bradford assay. Experiments were performed in quadruplicate and results expressed as a percentage (+s.e.) of the level in control cells in 4H medium.
Detection of thyroglobulin by immunocytochemistry
Monolayers were ®xed with methanol (10 min, at 7208C), permeabilized with 0.1% Triton-6100 in PBS (15 min), and non-speci®c antibody binding blocked with 10% FCS in PBS (30 min). Cells were then incubated with a rabbit polyclonal anti-human thyroglobulin antibody (Dako, Carpinteria CA, USA) at a 1 : 500 dilution for 1 h, followed by rhodamineconjugated goat anti-rabbit IgG (Southern Biotechnology) (1 h). The percentage of cells containing immunodetectable cytoplasmic Tg was scored for at least 300 cells per dish and results expressed as mean+s.e. of quadruplicate dishes (or colonies in the case of primary cells).
Semi-quantitative RT ± PCR analysis of NIS expression
Cells were grown to con¯uence in 6-well plates, in 4H or 5H medium+IBMX. RNA was extracted (Chomczynski and Sacchi, 1987 ) and reverse-transcribed using an oligo-dT primer (Ajjan et al., 1998) . PCR was performed in a 50 ml reaction containing 2.5 units Taq polymerase (Promega), 0.1 mM of each dNTP, and 1.5 ml of cDNA, in a buer consisting of 1 mM MgCl 2 , 10 mM Tris HCl, 0.01% gelatin, 50 mM KCl, 0.1% Tween and 0.1% NP40. Ampli®cation was performed using 30 cycles of 948C, 1 min; 558C, 1 min; and 728C, 1 min. The NIS primers were designed using the published rat sequence (Dai et al., 1996) as follows: forward: 5'-CTG CGA CTC TCC CAC TGA-3' and reverse: 5'-CGC AGC TCT AGG TAC TGG TA-3'. In addition, the following b-actin primers were used as an internal standard: forward: 5'-GTG GGG CGC CCC AGG CACCA-3' and reverse: 5'-CTC CTT AAT GTC ACG CAC GAT TTC-3'. Control reactions omitting the reverse transcription step were also performed to exclude the possibility of genomic contamination. Ten ml of the ampli®ed product were separated by agarose gel electrophoresis, stained with ethidium bromide and scanned into a Bio-Rad gel documentation system for quanti®cation of band intensity. Results are expressed as the ratio of NIS to b-actin signals and expressed as the mean+s.e. of triplicate determinations.
Statistics
The signi®cance of dierences between means was assessed by Student's t-test.
